In the RA training cohort, pathways related to the intestinal immune network for IgA production, allograft rejection, and antigen processing and presentation were activated, whereas those related to retinol metabolism, regulation of lipolysis in adipocytes, and tyrosine metabolism were inhibited (Fig. 5D,G). The gene discussed is CD79A; the disease is rheumatoid arthritis.